Mechanisms of Innate Immune Regulation for Mucosal Homeostasis These studies will provide new insights into the integration of innate immune activation pathways required for the recognition of microbiota at mucosal surfaces. We have identified the guanine nucleotide exchange factor H1 (GEF-H1) encoded by the arhgef2 gene as a required component of innate immune regulation by CARD-domain containing NOD-like receptors. We hypothesize that GEF-H1 is a required signaling intermediate from which signals diverge to control either inflammatory or inhibitory immune responses during microbial pattern recognition. We will define key mechanisms that allow GEF-H1 to regulate innate immune responses by regulating receptor-interacting serine/threonine-protein kinases (Rips) and examine the protein domains and post-translational modifications of GEF-H1 responsible for the control of immune activation and suppression by microbial factors. Defining the functional role of this newly discovered central component of microbial pattern recognition will provide pivotal insights into the mechanisms that mediate mucosa specific control of innate immune responses and tissue repair in the highly antigenic environment of the intestine.

Public Health Relevance

A more precise definition of the mechanisms of microbial recognition pathways regulating innate first line immune defenses is required for the understanding of the basis of inflammatory bowel diseases. We will define key mechanisms that allow a newly discovered mediator of mucosal host defenses to regulate immune responses during microbial pattern recognition. The elucidation of the biology of this critical signaling intermediate will provide pivotal insights into the genetic basis of Crohn?s disease leading to mucosal inflammation and the mechanisms that are required for intestinal tissue repair.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI093588-01
Application #
8300429
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Rothermel, Annette L
Project Start
2011-08-02
Project End
2012-07-31
Budget Start
2011-08-02
Budget End
2012-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$362,389
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Lee, In-Ah; Low, Daren; Kamba, Alan et al. (2014) Oral caffeine administration ameliorates acute colitis by suppressing chitinase 3-like 1 expression in intestinal epithelial cells. J Gastroenterol 49:1206-16
Chiang, Hao-Sen; Zhao, Yun; Song, Joo-Hye et al. (2014) GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses. Nat Immunol 15:63-71
Chang, Sun-Young; Song, Joo-Hye; Guleng, Bayasi et al. (2013) Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation. Immunity 38:153-65
Conway, Kara L; Kuballa, Petric; Song, Joo-Hye et al. (2013) Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. Gastroenterology 145:1347-57
Chen, Xinhua; Yang, Guoxun; Song, Joo-Hye et al. (2013) Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. PLoS One 8:e64227
Parsons-Wingerter, Patricia; Reinecker, Hans-Christian (2012) For Application to Human Spaceflight and ISS Experiments: VESGEN Mapping of Microvascular Network Remodeling during Intestinal Inflammation. Gravit Space Biol Bull 26:2-12
van Driel, Boaz; Liao, Gongxian; Romero, Xavier et al. (2012) Signaling lymphocyte activation molecule regulates development of colitis in mice. Gastroenterology 143:1544-1554.e7
Zhao, Yun; Alonso, Carmen; Ballester, Isabel et al. (2012) Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1. Inflamm Bowel Dis 18:603-12
Sidhu, Maninder; Cotoner, Carmen Alonso; Guleng, Bayasi et al. (2011) Small molecule tyrosine kinase inhibitors for the treatment of intestinal inflammation. Inflamm Bowel Dis 17:2416-26